NCT00611026 · Interventional trial
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.
Overall registry status Completed
Phase 3
Conditions Overactive Bladder
Delaware Valley sites
- Pfizer Investigational Site · Bensalem, PA · Bucks County
- Pfizer Investigational Site · Hamilton, NJ · Mercer County
- Pfizer Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory